', 'auto', 'clientTracker'); ga('clientTracker.send', 'pageview');
Preview Mode Links will not work in preview mode

This podcast's purpose is to bring together the field of neuroprosthetics/brain machine interfaces/brain implants in an understandable conversation about the current topics and breakthroughs.

We hope to replace needing to read scientific papers on new research in an easy to digest way.

People can share thoughts or ideas to facilitate 'idea sex' to make the field of brain implants a smaller and more personal space.

Aug 17, 2020

Arvind Gupta is the founder and venture advisor at IndieBio, a biotech company accelerator based in San Francisco. Through an intense four-month program, IndieBio’s team guides a promising technological project into being an accomplished company. They pride themselves on being the home of tomorrow’s leading companies. In this episode, Arvind Gupta discusses his strategy in turning ideas into successful companies. 

 

Top three takeaways: 

  1. IndieBio collaborates with incredible technological innovations and strategizes the best way to set up a business that maximizes the impact of the invention and the value created by that invention. 
  2. IndieBio plans to build milestone-based businesses that can interface people with machines to get a greater quantification of personal thoughts and feelings. 
  3. 83% of the 116 companies IndieBio has funded are still alive today, totaling a worth of $2.3 billion. 

 

 

[0:00] Ladan introduces the episode and the guest, Arvind Gupta.  

 

[1:10] IndieBio is a biotech company accelerator, helping companies with business and scientific milestones. 

 

[4:10] Being based in San Francisco, the pool of investors is smaller but the market size is immense. 

 

[6:20] Before IndieBio, Gupta invested in Vivid Vision, which used virtual reality to cure lazy eyes and improve vision. 

 

[10:30] IndieBio is looking for ideas that are noninvasive, cognitive enhancements that provide a benefit to a large market size. 

 

[13:50] Over the course of four months, mentors, investors, and venture capitalists work in the IndieBio lab to de-risk the chosen companies towards success.

 

[17:00] 43% of all the companies funded by IndieBio have female cofounders and have better performance because of it. 

 

[19:30] The accelerated nature of IndieBio allows for intense work to quickly figure out the potential success rate of a project.